Molecular Biomarkers in Cancer will be presented by Scott Dessain, MD, Lankenau Institute for Medical Research, Wynnewood, PA.
MBoC is an educational initiative sponsored by Genentech BioOncology to provide a synopsis of fundamental and evolving concepts on key molecular biomarkers currently impacting the diagnosis and treatment of cancer.
This presentation includes:
-A historical perspective on prognostic and predictive biomarkers in cancer
-A review of biomarkers currently used in screening, diagnosis, disease monitoring, and drugresponse/resistance
-Details on advanced molecular techniques helpful in the detection and analysis of biomarkers
-Discussion of major challenges faced during conception, validation, and use of cancer biomarkers
-Tumor type profiling exercises that review the detection and use of biomarkers in clinical practice
Register online at www.genersvp.com.
Please note that this a non-promotional, industry sponsored event and is NOT accredited for CME.
Delaware Society for Clinical Oncology c/o Megan Hayes Medical Society of Delaware PO Box 8155, Newark, Delaware 19714 Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org This website brought to you by:
Terms and Conditions of Use
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds